Sicart Associates’s iShares Biotechnology ETF IBB Stock Holding History

Sicart Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,503	Closed	-$5.82M	–	75
2025 Q1	$5.82M	Sell	45,503 -538	-1%	-$73K	2.01%	21
2024 Q4	$6.09M	Sell	46,041 -1,437	-3%	-$202K	2.18%	20
2024 Q3	$6.91M	Hold	47,478	–	–	2.43%	18
2024 Q2	$6.52M	Buy	47,478 +38,698	+441%	+$5.17M	2.5%	16
2024 Q1	$1.2M	Buy	+8,780	New	+$1.2M	0.44%	45

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Sicart Associates's IBB Position: Q2 2025 in Review

Sicart Associates sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 45,503 shares — an estimated $5.82M sold.

Sicart Associates first reported a position in IBB in Q1 2024 and held it in 5 quarters. The position peaked at $6.91M in Q3 2024. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Sicart Associates reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Sicart Associates sold 45,503 iShares Biotechnology ETF shares in Q2 2025, an estimated $5.82M.
Sicart Associates first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 5 quarters.
Sicart Associates's iShares Biotechnology ETF position peaked at $6.91M in Q3 2024.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Sicart Associates's 13F filing for Q2 2025, filed 18 Jul 2025.